From the genetic code to new antibiotics
Biochemist Christine Dunham and her colleagues illuminate a long-standing puzzle concerning ribosomes, the factories inside cells that produce proteins.
An indicator of aberrant stem cell reprogramming
Differences in DNA modifications (epigenetics) may explain why induced pluripotent stem cells aren’t quite the same as embryonic stem cells.
New opportunities in modulating microRNA
Emory geneticist Peng Jin and his colleagues have a review in the June 25, 2010 issue of Chemistry and Biology exploring whether microRNAs offer new possibilities for pharmacology.
Resurgence of interest in cancer cell metabolism
A recent article in Nature describes the resurgence of interest in cancer cell metabolism. This means exploiting the unique metabolic dependencies of cancer cells, such as their increased demand for glucose.
How muscles get stronger — and the nose knows
Scientists at Emory studying muscle repair have discovered an unexpected function for odorant receptors.
Look, don’t touch – noninvasive biochemistry
Imagine being able to decipher what’s going on inside cells simply by looking at them and watching the proteins and organelles shift in response to signals. That’s essentially what Yuhong Du and Haian Fu at the Emory Chemical Biology Discovery Center have been able to do.